IDT Australia Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
6,626.00
2,992.00
4,006.00
773.00
16,979.00
Depreciation, Depletion & Amortization
2,321.00
2,267.00
2,256.00
2,163.00
2,625.00
Other Funds
923.00
29.00
364.00
5,653.00
14,253.00
Funds from Operations
3,382.00
696.00
1,386.00
4,264.00
101.00
Changes in Working Capital
1,806.00
1,090.00
1,439.00
6,283.00
1,526.00
Net Operating Cash Flow
1,576.00
1,786.00
2,825.00
2,019.00
1,627.00
Capital Expenditures
512.00
17,278.00
7,130.00
7,567.00
2,358.00
Sale of Fixed Assets & Businesses
22.00
2.00
8.00
-
-
Net Investing Cash Flow
490.00
17,276.00
7,122.00
2,433.00
7,359.00
Issuance/Reduction of Debt, Net
1,943.00
366.00
2,138.00
1,928.00
-
Net Financing Cash Flow
3,903.00
16,776.00
9,839.00
3,944.00
122.00
Net Change in Cash
1,837.00
2,286.00
108.00
8,396.00
5,610.00
Free Cash Flow
1,797.00
2,468.00
7,165.00
253.00
2,545.00
Other Sources
-
-
-
10,000.00
9,717.00
Change in Capital Stock
5,846.00
16,410.00
7,701.00
5,872.00
-

About IDT Australia

View Profile
Address
45 Wadhurst Drive
Melbourne Victoria (VIC) 3155
Australia
Employees -
Website http://www.idtaus.com.au
Updated 07/08/2019
IDT Australia Ltd. produces, develops and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company specializes in the post-discovery pharmaceutical life cycle.